We describe here a case of high-grade vaginal squamous lesion in a 54-year-old woman with a papillomaviruses (HPV) genital infection that developed from a cervical low-grade squamous intraepithelial lesion (SIL) to a high-grade SIL (H-SIL) on cytological examination. A colposcopy exam led to the detection of suspect vaginal lesions with granulomatous infiltrations, which were classified as a Vaginal Intra-Epithelial Neoplasia grade 2 after pathologists' analyses. After a laser vaginal surgery and a loop excision of the transformation zone, the analyses of the anatomical pieces using a near-complete HPV screening panel revealed an HPV-4 infection that was not detected before in cervical smears. This HPV-infection is associated with a high human herpesvirus type 6A (HHV-6A) viral load in the same anatomical piece. The presence of an inherited chromosomally integrated HHV-6A (iciHHV-6A) was proved in this patient by real-time polymerase chain reaction on hair follicles and nail. This case suggests reconsidering both the benign nature of low-grade lesions in the female genital tract and the well-known “good” prognosis of low-risk HPV infection, especially when iciHHV-6A is diagnosed. This clinical course insists on the benefits of the multiplex panel use or global sequencing in order to optimize biological testing sensitivity, and so enhance clinical management of infection-induced neoplasia.

Keywords:
Human papillomaviruses, Inherited chromosomally integrated HHV-6A, Low-grade SIL, High-grade SIL, Vaginal intra-epithelial neoplasia, Genital cancer
1.
Maver PJ, Kocjan BJ, Seme K, Poljak M: Genomic diversity of low-risk human papillomavirus genotypes HPV 40, HPV 42, HPV 43, and HPV 44. J Med Virol 2014;86:272-282.
2.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
3.
Agut H, Bonnafous P, Gautheret-Dejean A: Update on infections with human herpesviruses 6A, 6B, and 7. Med Mal Infect 2017;47:83-91.
4.
Mardivirin L, Descamps V, Lacroix A, Delebassée S, Ranger-Rogez S: Early effects of drugs responsible for DRESS on HHV-6 replication in vitro. J Clin Virol 2009;46:300-302.
5.
Grussendorf-Conen EI, Gissmann L, Hölters J: Correlation between content of viral DNA and evidence of mature virus particles in HPV-1, HPV-4, and HPV-6 induced virus acanthomata. J Invest Dermatol 1983;81:511-513.
6.
Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC: Infection of natural killer cells by human herpesvirus 6. Nature 1993;362:458-462.
7.
Alvarez-Lafuente R, De las Heras V, Bartolomé M, Picazo JJ, Arroyo R: Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 2004;61:1523-1527.
8.
Razzaque A: Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990;5:1365-1370.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.